Project description
Novel breast imaging for precision medicine
Molecular heterogeneity may be responsible for the partial response to treatment observed in many types of cancer, including breast cancer. Precision medicine approaches should make great strides in solving this issue, but require technologies capable of genomic, molecular and physiological characterisation of the different tumours. Towards this goal, the EU-funded BREAST4D project will develop a novel functional imaging modality based on breast computed tomography. The approach involves the continuous acquisition of X-ray breast CT images for a period of minutes, with very high detail; then, following a radiomics-based analysis, a full identification and characterisation of tumour heterogeneity is achieved. The implementation of this novel modality is expected to improve treatment efficacy and response in breast cancer patients.
Objective
The next major step forward in the fight against breast cancer will be the introduction of personalized treatment. Such a precision medicine approach would maximize the rate of complete response, minimize ineffective therapy and morbidity, and eliminate the need for localized breast cancer surgery.
To achieve this, I will create a novel functional imaging modality, 4D dynamic contrast enhanced dedicated breast computed tomography (4D DCE-BCT), capable of characterizing every different genomic, molecular, and physiologic region present in a breast tumor. 4D DCE-BCT will involve putting together the hardware necessary for the continuous acquisition of x-ray breast projections with advanced techniques, for a period of minutes. Combined with new image reconstruction, correction, and processing algorithms, these acquisitions will result in quantitatively accurate 4D images of breast perfusion, with voxels thousands of times smaller, and a temporal resolution 27x and a limiting spatial resolution 6x higher than those in current imaging modalities. Radiomics-based analysis of these images will allow me to fully identify and characterize the tumor heterogeneity, known to result in regions with different therapy resistance.
Complete characterization of the tumor will allow for optimal neoadjuvant treatment planning, maximizing the probability of achieving pathologic complete response (pCR) and minimizing the risk of recurrence. Due to its relative affordability and safety, the use of 4D DCE-BCT for treatment response monitoring throughout treatment will be possible, making treatment adjustments possible, if needed. Finally, I envision that 4D DCE-BCT will be able to predict and determine that pCR is achieved, making surgery to excise any remnant viable tumor cells unnecessary.
The next era in breast cancer treatment is patient-specific care. The advanced imaging developed and introduced in this project will usher in this new era.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.1. - EXCELLENT SCIENCE - European Research Council (ERC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
ERC-COG - Consolidator Grant
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) ERC-2019-COG
See all projects funded under this callHost institution
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
6525 GA NIJMEGEN
Netherlands
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.